Our latest report challenges the accuracy of recent MA spending estimates by MedPAC, exposing critical flaws in the Commission’s revised methodology underpinning its skewed estimates, and calls for greater transparency in evaluating the MA program.
A briefing document summarizing key takeaways from the report is available here.